Announcements

Director Evelyn D'An filed a Form 4 with the SEC on November 6, 2026, disclosing the grant of a stock option to purchase 5,000 shares of Matinas BioPharma Holdings, Inc. common stock under the company's 2025 Equity Incentive Plan.

Impactive Capital LP filed a Form 144 notice of proposed sale with the U.S. Securities and Exchange Commission on November 6, 2026, disclosing plans to sell 34,577 shares of WEX Inc. common stock through Goldman Sachs & Co. LLC on the New York Stock …

Director Edward Shapiro filed a Form 4 with the SEC on November 6, 2026, disclosing a charitable donation of 50,000 shares of United Airlines Holdings, Inc. common stock on November 4, 2026.

Turtle Creek Asset Management Inc. filed a Form 4 with the SEC on November 6, 2026, reporting the sale of JELD-WEN Holding, Inc. common stock across three managed funds on November 4, 2026.

Baker Bros. Advisors LP and affiliated reporting persons filed Amendment No. 5 to Schedule 13D with the SEC on November 6, 2026, disclosing a beneficial ownership position of 9.99% in Madrigal Pharmaceuticals, Inc. following additional acquisitions of common stock.

Joseph D. Mansueto, Executive Chairman and 10% owner of Morningstar, Inc., filed a Form 4 on November 6, 2026, disclosing five open-market sales of Morningstar common stock totaling 7,250 shares executed on November 5, 2026, pursuant to a Rule 10b5-1 trading plan.

PROCEPT BioRobotics Corp's Chief Strategy/Marketing Officer Pooja Sharma filed a Form 4 on November 6, 2026, disclosing the disposition of 4,710 shares of common stock through the company's sell-to-cover process for tax withholding obligations connected to restricted stock unit vesting.